Hits:Updated:2019-01-19 09:01:34【Print】
In recent years, the state has issued a number of policies to support domestic medical device companies. For example, the research and development phase provides direct clinical support for advanced medical devices, and the green channel is provided at the stage of listing approval. The domestic sales of medical devices are encouraged during the tender sales phase. The publication and landing of these policies have greatly supported the development of domestic medical device companies.
Many companies have experienced changes in the market. The penetration rate of domestic leading companies in some sub-sectors in the first-tier cities is gradually increasing. The purchases of domestic medical devices in many hospitals are constantly increasing.
In 2014, the Food and Drug Administration issued the “Special Approval Procedure for Innovative Medical Devices (Trial)”. In 2016, the Food and Drug Administration issued the “Notice on the Priority Approval Process for Medical Devices”. As of the end of last year, there were 273 special approval applications. After being submitted, it was determined that 63 products entered the special approval channel, and a total of 12 innovative products were approved for registration. The industry believes that the strong support of the policy is an important cornerstone of the research and development of domestic medical devices. On this basis, some domestically produced products in high-growth segments have achieved good results.
In the past two years, we can say that our domestic medical equipment, the share of procurement is gradually expanding, specifically, it should be different equipment, such as color ultrasound is very high, there are some like CT magnetic resonance, the domestic share is relatively low.
|
